| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |